Trailing-twelve-month (TTM) revenue is $450.45 Million with a year-over-year growth of +15.14%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $111,679,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q3 FY2026Period ended 2025-12-31 | $113,487,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-09 |
| Q4 FY2026Period ended 2026-03-31 | $114,490,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-15 |
| Q1 FY2027Period ended 2026-06-30 | $110,793,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $450,449,000 |
Current P/S: $368,450,145 market capitalization ÷ $450,449,000 TTM revenue = 0.82x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:45:34.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $110.79M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:45:45.747Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232022-12-31 · USD | FY20242023-12-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|
| Product | $56M | $50M | $84M |
| Service | $79M | $84M | $360M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232022-12-31 · USD | FY20242023-12-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|
| Africa | N/A | N/A | $110M |
| AUSTRALIA | N/A | N/A | $43M |
| Europe And Middle East | N/A | N/A | $51M |
| ISRAEL | $44M | $42M |
$450.45M
$450.45 Million
+15.14%
vs. $391.22M a year ago (TTM)
+30.38%
5 Year compound annual growth rate
1 Year
+15.14%
3 Year
+50.14%
5 Year
+30.38%
10 Year
+27.36%
15 Year
+19.82%
20 Year
+15.66%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $443.78M | +$81.26M | +22.42% |
| 2025 | $362.51M | $0 | +0.00% |
| 2024 | $362.51M | +$227.36M | +168.22% |
| 2023 | $135.16M | +$9.20M | +7.30% |
| 2022 | $125.96M | +$12.37M | +10.89% |
| 2021 |
TTM Growth
+15.14%
3-Year CAGR
+50.14%
5-Year CAGR
+30.38%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:45:45.747Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Other | $34M | $33M | $22M |
|---|
| UNITED STATES | $57M | $59M | $159M |
|---|
| $113.59M |
| +$31.68M |
| +38.67% |
| 2020 | $81.92M | +$28.85M | +54.37% |
| 2019 | $53.06M | +$12.11M | +29.56% |
| 2018 | $40.96M | +$4.14M | +11.23% |
| 2017 | $36.82M | ($4.96M) | (11.88%) |
